Clinical Trial Update: TKIs vs. Pertuzumab in HER2+ Breast Cancer Patients With Active Brain Metastases (HER2BRAIN) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing tyrosine kinase inhibitors versus pertuzumab in HER2-positive breast cancer with active brain metastases is ongoing with unknown enrollm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: HER2-positive Breast Cancer, Brain Metastases | Phase 2 | Status: UNKNOWN